Biocept: Jumps on swing to Q4 profit after COVID-19 testing demand surges

Biocept

30/03/2021 11:26

** Molecular diagnostics co's shares  BIOC.O  rise 23.3% to
$6.35
    ** Says Q4 revenue increased more than eight fold to $18.5
mln, boosted by robust demand for its COVID-19 testing services
 urn:newsml:reuters.com:*:nBw60Zyqca
    ** Reports Q4 net income attributable to common stockholders
of $1.9 mln vs net loss of $5.7 mln the previous year
    ** Q4 was co's first profitable quarter; Co received about
140,000 samples for COVID-19 testing during the quarter - BIOC
    ** Stock gained about 16% YTD, as of last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))